Sexual Function Preserved in Prostate Cancer Combination Therapy
High rates of preserved sexual function with combination beam plus brachytherapy.
Diagnosis & Disease Information
Brachytherapy Offers Favorable Long-Term Prostate Cancer Survival
Study finds a 15-year cancer-specific survival rate of 94%; hormone therapy for more than 6 months decreases all-cause survival.
Post-Brachytherapy Erectile Function Preserved in Most Men
At 5 years after seed implantation, 59% prostate cancer patients had preserved erectile function.
Post-Brachytherapy PSA Bounce Linked to Sexual Activity
PSA bounce was associated with significantly higher scores on the International Index of Erectile Function-15 questionnaire.
Prostate Brachytherapy On the Decline
Use of this treatment for localized prostate cancer has been decreasing since 2002, perhaps due to increasing use of radical prostatectomy.
Radiotherapy Combo Superior for Intermediate-Risk Prostate Cancer
IMRT plus brachytherapy offers better PSA relapse-free and metastasis-free survival than high-dose IMRT alone.
Radiation Combo for High-Risk Prostate Cancer Offers Good Outcomes
In a study, the five-year biochemical failure-free survival rate was nearly 85%.
New Approach Promising for Penile Cancer
Researchers report good results using high-dose rather than low-dose interstitial brachytherapy.
Brachytherapy a Good Option for Younger Prostate Cancer Patients
By itself or combined with external beam radiation therapy, it offers excellent oncologic outcomes.
Focal Therapy for Prostate Cancer Advances
Modalities under investigation include laser ablation, hemiablative seed implantation, and results are promising.
- Loading...
Loading...
Loading... 
Loading...